Details
Stereochemistry | RACEMIC |
Molecular Formula | C17H25NO2.ClH |
Molecular Weight | 311.847 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCC(=O)O[C@]1(C[C@H](C)N(C)C[C@H]1C)C2=CC=CC=C2
InChI
InChIKey=USGVEUCDHRWIRO-RECIXLKMSA-N
InChI=1S/C17H25NO2.ClH/c1-5-16(19)20-17(15-9-7-6-8-10-15)11-14(3)18(4)12-13(17)2;/h6-10,13-14H,5,11-12H2,1-4H3;1H/t13-,14+,17+;/m1./s1
Molecular Formula | C17H25NO2 |
Molecular Weight | 275.3859 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Trimeperidine (promedol) is the earliest and mostly studied opioid analgesic. Trimeperidine stimulates opioid receptors in the central nervous system. Compared with morphine, it has a weaker and shorter analgesic effect, less affects the respiratory, vomiting and vagal centers, does not cause smooth muscle spasm (except for the myometrium), and has a moderate antispasmodic and hypnotic effect. It is used to treat severe pain syndrome, acute left ventricular failure, pulmonary edema, cardiogenic shock, preparation for surgery, childbirth, high fever, post-transfusion complications, poisoning with atropine, barbiturates, barium, gasoline, boric acid, strong acids, carbon monoxide, turpentine, formalin, formalin. It has several side effects. Administration of this substance is associated with the development of life-threatening conditions accompanied by the suppression of respiration center. Analgesic trimeperidine (promedol) was included into the health care kits by various Ministries of the Russian Federation at different times.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Use of lornoxicam for analgesia in the early postoperative period]. | 2001 May-Jun |
|
[Combined use of narcotic analgesics and non-steroidal anti-inflammatory drugs in the analgesia of injured patients before hospitalization]. | 2002 Jul-Aug |
|
[Study of analgesic efficacy of propacetamol in the postoperative period using a double blind placebo controlled method]. | 2002 Jul-Aug |
|
[Use of analgesics with peripheral action in the system of complex protection of the patient from operative trauma]. | 2002 Jul-Aug |
|
[Use of epidural analgesia for the arresting of pronounced lumbar pains]. | 2003 Jul-Aug |
|
[Clinical aspects of using patient-controlled analgesia with nonsteroidal anti-inflammatory agents in postoperative period]. | 2003 Sep-Oct |
|
[Postoperative analgesia with nonsteroid anti-inflammatory drugs in children]. | 2004 Jan-Feb |
|
[Analgesic and opioid-sparing effects of intravenous paracetamol in the early period after aortocoronary bypass surgery]. | 2008 Sep-Oct |
|
[Multimodal approach to postoperative analgesia in patients with neuropathic pain]. | 2008 Sep-Oct |
|
[Comparison of analgesics using two devices for the patient-controlled analgesia]. | 2009 Jul-Aug |
|
[Impact of preemptive analgesia on postoperative pain syndrome in laparoscopic surgery]. | 2009 Nov-Dec |
|
[Anesthetic maintenance during circular face lifting]. | 2010 Mar-Apr |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 04:40:41 GMT 2023
by
admin
on
Sat Dec 16 04:40:41 GMT 2023
|
Record UNII |
U3696V8BXT
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID90924988
Created by
admin on Sat Dec 16 04:40:41 GMT 2023 , Edited by admin on Sat Dec 16 04:40:41 GMT 2023
|
PRIMARY | |||
|
21117286
Created by
admin on Sat Dec 16 04:40:41 GMT 2023 , Edited by admin on Sat Dec 16 04:40:41 GMT 2023
|
PRIMARY | |||
|
U3696V8BXT
Created by
admin on Sat Dec 16 04:40:41 GMT 2023 , Edited by admin on Sat Dec 16 04:40:41 GMT 2023
|
PRIMARY | |||
|
SUB04968MIG
Created by
admin on Sat Dec 16 04:40:41 GMT 2023 , Edited by admin on Sat Dec 16 04:40:41 GMT 2023
|
PRIMARY | |||
|
42325-78-0
Created by
admin on Sat Dec 16 04:40:41 GMT 2023 , Edited by admin on Sat Dec 16 04:40:41 GMT 2023
|
PRIMARY | |||
|
125-80-4
Created by
admin on Sat Dec 16 04:40:41 GMT 2023 , Edited by admin on Sat Dec 16 04:40:41 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
100000084645
Created by
admin on Sat Dec 16 04:40:41 GMT 2023 , Edited by admin on Sat Dec 16 04:40:41 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |